Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, giving secure, large-purity supplies for getting old and most cancers investigate. Daily laboratory workflows generally expose a persistent challenge: the sluggish and inefficient removing of senescent cells that impair t